TrialMolecular and cellular biochemistry2018
ACE2, CALM3 and TNNI3K polymorphisms as potential disease modifiers in hypertrophic and dilated cardiomyopathies.
Amit Kumar et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this paperpooled itcites it